Named Target definition

Named Target means, as applicable, GITR, LAG-3, OX-40, XXX-3 or the Target as to which an Assumed Project is directed.
Sample 1Sample 2
Named Target means, as applicable, GITR, LAG-3, OX-40, TIM-3 or the Target as to which an Assumed Project is directed.
Sample 1

Examples of Named Target in a sentence

  • Upon any termination of this Agreement with respect to a Product, or the Agreement in its entirety, the exclusivity under Section 2.10 shall no longer apply with respect to the underlying Named Target or Accepted Target.

  • Each Named Target Stockholder and the other persons set forth on Schedule 1(a) shall have executed and delivered to the Buyer a Noncompetition Agreement, and none of such Persons shall be in breach thereof.

  • Each Named Target Stockholder shall have executed and delivered to the Buyer the Voting and Joinder Agreement, and none of such Persons shall be in breach thereof.

  • To the extent permitted under the terms of the Collaborative Research, Development and Commercialization Agreement between the parties effective as of July 15, 1994 (the "1994 Agreement"), Chiron may, in its sole discretion, propose such Target as an additional or substitute Named Target under the 1994 Agreement.

  • For example, if a first Merck Antibody in a non-terminated Project is directed against the Target set forth on Schedule 1.64 and a [*] Merck Antibody in a non-terminated Project is directed against the Target set forth on Schedule 1.64 and one other Target that is not an Accepted Target or a Named Target, then Merck shall only be required to designate one other Additional Target pursuant to Section 2.5 against such other Target.

  • Subject to Sutro’s fulfillment of its obligations under this Agreement, Merck shall use Commercially Reasonable Efforts to Develop and seek Regulatory Approval for [*] for each Named Target and Accepted Target, and after receiving Regulatory Approval for any such Product, shall use Commercially Reasonable Efforts to Commercialize such Product, provided, that 27 *Confidential Treatment Requested.

  • The parties hereby agree that, as of the Effective ------------------- Date of this Amendment, (i) HIV shall cease to be a Named Target and may not hereafter be nominated as a Named Target, a Suggested Target or a Potential Named Target under the Agreement and (ii) RPI shall be entitled to all rights of a Developing Party of a Solely Developed Product with respect to any Product containing or utilizing an HIV Target ("HIV Product"), subject to the following terms and conditions.

  • Notwithstanding the foregoing, Merck shall only have the right to replace a Named Target or Accepted Target in accordance with this Section 2.4 and the procedure set forth in Section 2.9 during the [*] year period following the Effective Date.

  • For clarity, if the JSC elects to remove a Target from the list of Bullpen Targets, any Antibody that Interacts with such Bullpen Target shall no longer be subject to this Section 2.7(c) but only if such Antibody does not Interact with a Named Target or another Bullpen Target.

  • Xxxxx shall be entitled to select one “Lead Product” that is a Compound achieving Proof of Principle that is Directed To an Initially Named Target and designate one or more other Compounds achieving Proof of Principle as “Products” to be further Developed hereunder.

Related to Named Target

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Valid write-in candidate means a candidate who has qualified as a write-in

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • hit means the existence of a match or matches established by the Central System by comparison between biometric […] data recorded in the computerised central database and those transmitted by a Member State with regard to a person, without prejudice to the requirement that Member States shall immediately check the results of the comparison pursuant to Article 26(4);

  • Exempt compound means the same as defined in Rule 2.

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • Acquisition Target means any Person becoming a Subsidiary of the Company after the date hereof; any Person that is merged into or consolidated with the Company or any Subsidiary of the Company after the date hereof; or any Person with respect to which all or a substantial part of that Person’s assets are acquired by the Company or any Subsidiary of the Company after the date hereof.

  • Antibody means a molecule comprising or containing one or more immunoglobulin variable domains or any fragments, derivatives, variants or modifications thereof that bind to the same antigen.

  • Licensed Compound means [***].

  • Sanctioned Target means any target of Sanctions, including (i) persons on any list of targets identified or designated pursuant to any Sanctions, (ii) persons, countries, or territories that are the target of any territorial or country-based Sanctions program, (iii) persons that are a target of Sanctions due to their ownership or control by any Sanctioned Target(s), or (iv) persons otherwise a target of Sanctions, including vessels and aircraft, that are designated under any Sanctions program.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Opioid antagonist means a drug that binds to opioid

  • Development Milestone Event has the meaning set forth in Section 7.2.1.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Biosimilar Product means, with respect to a Licensed Product and on a country-by-country basis, a product that [***].

  • continuing candidate means any candidate not deemed to be elected, and not excluded,

  • Program Patent Rights means any Patent Rights that contain one or more claims that cover Program Inventions.

  • Development Milestone is defined in Section 5.3.

  • Replacement Candidate means any Candidate Introduced by the Agency to the Client to fill the Engagement following the Introduction of another Candidate whose Engagement either did not commence or was terminated during the first 12 weeks of the Engagement;